top of page

List of selected publications from our team

Hurst JR, Han MK, Singh B, Sharma S, Kaur G, de Nigris E, Holmgren U, Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respir Res. 2022 Aug 23;23(1):213. doi: 10.1186/s12931-022-02123-5. PMID: 35999538; PMCID: PMC9396841

Pandey, S.P., 2020. NM3 Extending the Network Meta-Analysis (NMA) Framework to Multilevel Network Meta-Regression (ML-NMR): A Worked Example of ML-NMR VS Standard NMA, Value in Health, 23, S407

Pandey, S.P., 2020. PCN61 Healthcare Costs Comparison of Nivolumab Versus Placebo As Adjuvant Treatment of Patients with Melanoma: A Propensity Score Matched Analysis, Value in Health, 23, S432-S433

Pandey, S.P., 2020. AI3 Prediction of breast cancer using K-NEAREST neighbour: a supervised machine learning algorithm, Value in Health, 23, S1

Pandey, S.P., 2020. PCN292 Bayesian network meta-analyses of overall survival: application of different parametric and fractional polynomial method, Value in Health, 23, S575

Pandey, S.P., 2019. PCN264 Estimating the burden of salivary gland cancer in Nordic countries: a predictive analysis using time series analysis methods, Value in Health, 22, S487

Sharma, A.S., 2019. PCN268 Estimating the burden of malignant haematopoietic cancers in nordic countries: a predictive analysis using time series analysis methods, Value in Health, 22, S487-S488

Shukla, P.S., 2018. A Comparison of Patient Level Data (IPD) Regression Techniques In Adjusting For Cross Trial Differences In An Indirect Treatment Comparison (ITC): A Worked Example Of Simulated Treatment Comparison (STC) Vs Bayesian IPD Regression, Value in Health, 21, S228


Attri S., Kaur N., Singh B., Impact of Out-Of-Pocket (OOP) cost on Breast Cancer (BC) treatment persistence in the US: A systematic literature review (SLR), ESMO 2022, Paris

Bourdin A., Molinari N., Ferguson G.T., Singh B., Siddiqui M.K., Holmgren U., Ouwens M., Jenkins M., De Nigris E. Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Adv Ther. 2021 Apr 30. doi: 10.1007/s12325-021-01703-z. Epub ahead of print. PMID: 33929661.

Hurst J.R., Singh B., Varghese P., Holmgren U., De Nigris E. A Systematic Literature Review of the Humanistic Burden of COPD. IJCOPD 2021: 16, 1303-1314

Ferguson G.T., Darken P., Ballal S., Singh B., Attri S., Holmgren U., de Nigris E., Efficacy of Budesonide/Glycopyrronium/ Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 2020;37(6):2956-2975.

Pandey S., Sharma A., Singh B., Vanderpuye-Orgle J., Bayesian network meta-analyses of overall survival- application of different parametric and fractional polynomial methods. Value in Health, 2020;23(1):S75.

Singh B., Sharma S., Kaur G. de Nigris E., Holmgren U., Prognostic Risk Factors of Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Systematic Literature Review. Value in Health, 2020

Zheng Y., Vioix, H. Liu F.X. Singh B., Sharma S., Sharda D., Diagnostic and Economic Value of Liquid Versus Solid Tissue Biopsy Procedures for the Detection of Targetable Mutations in Non-Small Cell Lung Cancer (NSCLC) Tumors: A Literature Review. IASLC 2020

Zheng Y., Vioix, H. Liu F.X. Singh B., Sharma S., Sharma S., Diagnostic and Economic Value of Next-Generation Sequencing (NGS) in Genotyping Non-Small Cell Lung Cancer Tumors (NSCLC): A Literature Review. IASLC 2020

Singh B., Attri S., Kaur G., Flynn J.A., First-line Maintenance and Second-line Treatment of Advanced or Metastatic Gastric Cancer- a Systematic Review of Literature. Value in Health, 2020

Siddiqui M.K., Singh B., Attri S., Veraart C., Harty G., Wong S.L., Use of rituximab in adults with relapsing-remitting multiple sclerosis: a systematic literature review, Current Medical Research and Opinion, 2020;36(5):809-826

Singh B., Sharma S., Walia S., Chavda R., Impact of itch on sleep in Adults with Atopic Dermatitis: A Targeted Literature Review. Value in Health, 2020;22(SUPPL):S103. 

Singh B., Pandey S., Mangat G., Kaur G., Mishra N., Siddiqui M.K., Sharma S., Bayesian Network Meta-Analyses of the Efficacy of LONG-Acting Release Somatostatin Analogs in Patients with Advanced Neuroendocrine Tumors: Application of Different Parametric and Fractional Polynomial Methods. Value in Health, 2020;22(SUPPL):S5-S6.

Singh B., Sharma A., Mangat G., Pandey S., Siddiqui M.K., Sharma S., A Meta-Analysis of Efficacy and Safety of Vesicular Monoamine Transporter Type 2 Inhibitors for Treatment of Huntington Chorea. Value in Health, 2020;22(SUPPL):S74.


de Nigris, E., Singh B., Siddiqui M.K., Holmgren U., Economic Burden of Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. American Journal of Respiratory and Critical Care Medicine 2020

Singh B., Verma M., Sharma S., Bethi S., Sharma S., Breast cancer scanning using somatostatin analogues: Systematic review and meta-analyses. Value in Health, 2020;22(SUPPL3):S515.

Sharma N., Singh B., Siddiqui K.S., Nigris E.D., Holmgren U., Cabrera C., Arnetorp S., Epidemiological burden of moderate-to-very severe COPD: a systematic literature review. European Respiratory Journal 2019 54: PA3332

Singh B., Sehgal M., Pricing, and reimbursement frameworks in China, Japan, and South Korea with a focus on key reimbursement drivers. Value in Health, 2020;21(SUPPL):S2.

Sharma N., Singh B., Siddiqui K.S., Nigris E.D., Holmgren U., Cabrera C., Arnetorp S., Global treatment guidelines and patterns in COPD: focus on triple therapy. Thorax 2019;74:A234

Singh B., Mourya A., Sah S.P., Kumar A., Protective effect of losartan and ramipril against stress-induced insulin resistance and related complications: Anti-inflammatory mechanisms. Eur J Pharmacol. 2017;80: 54-61

Kaur G., Cholia R.P., Mantha A.K., Kumar, R., DNA Repair and Redox Activities and Inhibitors of APE1/Ref-1: A Comparative Analysis and their Scope and Limitations toward Anticancer Drug Development. J. Med. Chem, 2014, 57 (24)

Kumar D., Kaur G., Negi A., Kumar S., Singh S., Kumar R., Synthesis and Xanthine Oxidase Inhibitory Activity of 5,6-Dihydropyrazolo/pyrazolo[1,5-c]quinazoline Derivatives, accepted in Bioorg. Chem, 2014, 57 

Kaur G., Cholia R.P., Joshi G., Kumar R, Anticancer activity of dihydropyrazolo[1,5‐c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II. Archiv der Pharmazie, 2018, 351(6)

Kaur G., Rai P., Sharma, S., Economic burden of Huntington’s disease in Europe. Value in health, 2019, 22 (3); S741

bottom of page